ArticleBlood2022

Cutler C, Lee SJ, Arai S, et al. Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar study. Blood. 2021;138(22):2278-2289.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.